Table 1. Summary of site specificity of mouse antibodies against BoNT/A and the three HN peptides HN519–845, HN729–845 and HN519–593*.
| Peptide | Sequence | Abs againstBoNT/A | Abs againstPeptide | Abs againstPeptide | Abs againstPeptide |
|---|---|---|---|---|---|
| Number | Position | Toxoid | HN519–845 | HN729–845 | HN519–593 |
| N5 | 505–523 | − | |||
| N6 | 519–537 | +++ | ++++ | +++++ | |
| N7 | 533–551 | +++ | +++ | ++++ | |
| N8 | 547–565 | +++++ | ++ | ++ | |
| N9 | 561–579 | ++++ | ++ | +++++ | |
| N10 | 575–593 | + | − | + | |
| N11 | 589–607 | − | − | ||
| N12 | 603–621 | − | − | ||
| N13 | 617–635 | − | − | ||
| N14 | 631–649 | ± | − | ||
| N15 | 645–663 | − | − | ||
| N16 | 659–677 | − | − | ||
| N17 | 673–691 | ± | − | ||
| N18 | 687–705 | − | − | ||
| N19 | 701–719 | + | − | ||
| N20 | 715–733 | ± | − | ||
| N21 | 729–747 | − | +++++ | ++++ | |
| N22 | 743–761 | + | +++++ | + | |
| N23 | 757–775 | − | +++ | ++ | |
| N24 | 771–789 | + | − | ± | |
| N25 | 785–803 | +++++ | ++ | − | |
| N26 | 799–817 | − | ++++ | +++ | |
| N27 | 813–831 | +++ | + | + | |
| N28 | 827–845 | +++ | + | ± | |
| N29 | 841–859 | − |
*The number of + signs indicates the strength of antibody binding to the respective peptide.